• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Strategic Analysis of Indian Biosimilar Market Product Image

Strategic Analysis of Indian Biosimilar Market

  • Published: May 2011
  • Region: India
  • 81 Pages
  • Frost & Sullivan

FEATURED COMPANIES

  • Biocon
  • Dr Reddy’s
  • Intas Pharmaceuticals
  • Ranbaxy
  • Shantha Biotechnics
  • Wockhardt
  • MORE

This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the biosimilars, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developments. The research deliverable also covers the overview of the other major biosimilar players like China. The research service also gives a deeper insight into the profiles of the companies that are into this segment in India. It also covers the historical trends and future impacts on Biosimilar Markets.

This Frost & Sullivan research service titled Strategic Analysis of Indian Biosimilar Market presents a comprehensive analysis of the market through primary research, including the evaluation of market size and components, as well as market opportunities, to enable decisions related to future strategies and investments.

Market Overview

Frost & Sullivan: India Emerges as Dominant Participant in the Biosimilar Market

Impending Patent Expiries Encourage Companies to Ramp up Biosimilar Manufacturing Capabilities

The Indian biosimilar market has witnessed READ MORE >

1. Research Objective and Methodology

2. Executive Summary

3. Global Biosimilar Market
- 3.1 Introduction to Biosimilars
- 3.2 Global Population Demographics
- 3.3 Key Biodrugs
- 3.4 Types of Products manufactured by Major Participants
- 3.5 Market Size of Biosimilars: Global
-- 3.5 a Biologics Patents expiring in 2011-2016
-- 3.5 b Biologics Patents expiring in 2016-2019
-- 3.5 c Worldwide sales of Key Biodrugs
-- 3.5 d Opportunities in Market
-- 3.5 e Global Market Forecast
-- 3.5 f Major Participants: Global
-- 3.5 g Trends within global market

4. Indian Biosimilar Market
- 4.1 Overview of Indian Biosimilar Market
- 4.2 Timeline of Market
- 4.3 Biosimilar Value Chain in India
- 4.4 Indian Market Portfolio
- 4.5 Domestic Market Potential-Observed Trends in Market
- 4.6 Trends in Biosimilars moving ahead: Drivers, Restraints and Challenges
-- 4.6 a Market Drivers Ranked in order of impact
-- 4.6 b General Factors Favoring the Market
-- 4.6 c Market Restraints Ranked in order of impact
-- 4.6 d Key Restraints Summary
-- 4.6 e Hurdles faced by Indian participants
-- 4.6 f Observed Trends in Market
-- 4.6 g Export Potential -Overview
-- 4.6 h Expansion Strategy of Indian players
-- 4.6 I Highly Regulated Markets:
--- i Europe
--- ii United States
--- iii Semi-regulated Markets:
--- iv China
- 4.7 Cost Advantage of India
- 4.8 Indian Market Forecast: 2010-2015

5. Regulatory Scenario
- 5.1 Indian regulations for Biosimilars
- 5.2 International Regulatory Authorities
-- 5.2 a European Medicines Agency (EMA)
-- 5.2 b US-FDA (Food and Drug Administration)

6. Major participants in Indian Market
- 6.1 Biocon
- 6.2 Dr. Reddy’s
- 6.3 Ranbaxy
- 6.4 Wockhardt
- 6.4 Intas Pharmaceuticals
- 6.5 Shantha Biotechnics

7. Historical Trends and Future Impacts
- 7.1 2001-2010: A Historical View of the Biosimilars market
- 7.2 2010-2015: Frost & Sullivan View on the Biosimilars Market

8. Chinese Biosimilar Market
- 8.1 Chinese Biosimilar Market Overview
- 8.2 Major Players

9. About Frost & Sullivan

List of Figures

Biosimilar Market: Revenue of drugs nearing patent expiry (World), 2011-2019
Biosimilar Market: Revenue Forecasts (World), 2010-2015
Biosimilar Market: Market Portfolio (India), 2010
Biosimilar Market: Market Drivers Ranked in Order of Impact (India), 2010-2015
Biosimilar Market: Market Restraints Ranked in Order of Impact (India), 2010-2015
Biosimilar Market: Revenue Forecasts (India), 2010-2015

LOC:

Biosimilar Market: Revenues of key Biodrugs whose patents expire between 2011-2019 (World), 2009
Biosimilar Market: Revenue Forecasts (World), 2010-2015
Biosimilar Market: Market Share Analysis Company-wise (World), 2009
Biosimilar Market: Market Share Analysis Product-wise (India), 2009
Biosimilar Market: Revenue Forecasts (India), 2010-2015

- Biocon
- Dr Reddy’s
- Ranbaxy
- Wockhardt
- Intas Pharmaceuticals
- Shantha Biotechnics

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos